
Esketamine/Spravato Treatment
For Mood Disorders
Esketamine, also known by the brand name Spravato®, is an innovative, FDA-approved nasal spray treatment designed specifically for individuals struggling with treatment-resistant depression and other mood disorders. Unlike traditional oral antidepressants, Spravato® works rapidly by targeting the NMDA receptor in the brain, helping to restore connections between nerve cells and improve overall mood regulation. This cutting-edge therapy is administered in a certified clinical setting under medical supervision to ensure safety and effectiveness. At Affective Mental Wellness, we offer Spravato® as part of a comprehensive mental health treatment plan for individuals who have not found relief with other medications. If you're looking for a new path forward in managing depression, anxiety, or related mood disorders, Spravato® may be a transformative option.
Conditions Treated
With Esketamine
Understanding Esketamine/Spravato
What is ketamine?
Esketamine is a FDA approved anesthetic agent originally developed in 1962. It has been used primarily as an induction agent for general anesthesia in surgery for children, adults, and animals. Esketamine has a remarkable safety track record, hence its use in the pediatric population. Recently, it has been discovered that esketamine can be highly effective in treating depression, PTSD, bipolar disorder, OCD, and suicidal thoughts.
What disorders does esketamine treat?
Esketamine is most commonly used to treat chronic depression, bipolar disorder, anxiety, PTSD, OCD, and suicidal thoughts. It can also be used as treatment for chronic pain among other conditions.
Do I need a referral from my primary care physician?
No, any licensed mental health care professional or physician can refer you.